Agency for Medicinal Products and Medical Devices of Croatia

Recent papers from Agency for Medicinal Products and Medical Devices of Croatia

1. Availability and reimbursement of fixed-dose combination medicines for hypertension treatment in Central and Eastern EuropeFrontiers in Pharmacology · 2026
2. Evaluation of commercially available low molecular mass heparin products: an internal market surveillance study2026
3. An Overview of Antibiotic Consumption in Croatian Counties, 2017–2024: Temporal and Geographic Patterns Before, During, and After the COVID-19 PandemicPharmacoepidemiology · 2026
4. Timing and rate of reimbursement for cystic fibrosis modulator therapies in EU countriesJournal of Cystic Fibrosis · 2026
5. An Overview of In Vitro Release Methods for Long-Acting Injectable Products Based on PLGAMethods and Protocols · 2026
6. Effects of exercise on depression and anxiety in university students: a systematic review and meta-analysisFrontiers in Sports and Active Living · 2026
7. Investigation of VIM-1-producing Enterobacter spp. across Switzerland: clonal dissemination and plasmid transmissionAntimicrobial Agents and Chemotherapy · 2026
8. ABCG2 Genetic Variability in Drug Exposure and Toxicity: Implications for Clinical PracticeToxics · 2026
9. Anti‐amyloid antibodies in Europe: Where are we now?British Journal of Clinical Pharmacology · 2026
10. The evolving therapeutic landscape of spinal muscular atrophy - A scoping review of investigational agents, emerging delivery technologies and strategic innovations.2026
11. CYP3A4‐Mediated Metabolism and Drug–Drug Interaction Potential of Abemaciclib and Letrozole In VitroChemistry & Biodiversity · 2026
12. Accelerating cancer treatment optimisation: A multistakeholder roadmap from the Cancer Medicines ForumJournal of Cancer Policy · 2026
13. The Influence of Excipients’ Chemical Nature on the Degradation of Metformin and VildagliptinKemija u industriji · 2025
14. Validation of the metrics properties of ‘UO Pharma’: a new French tool for measuring hospital pharmaceutical activityJournal of Pharmaceutical Health Services Research · 2025
15. Chemometrically-supported quality assessment of chamomile teaActa Pharmaceutica · 2025
16. Diverging Safety Signals: A Trend Analysis of Suspected Adverse Drug Reactions Reporting for Spinal Muscular Atrophy Therapies in the European UnionNeurology International · 2025
17. Analysis of total cholesterol results measured in the initial period of the Croatian screening program for familial hypercholesterolemia: a pilot studyClinical Chemistry and Laboratory Medicine (CCLM) · 2025
18. High-performance liquid chromatography method for simultaneous determination of the degradation products of metformin hydrochloride and vildagliptinEuropean Journal of Pharmaceutical Sciences · 2025
19. Identifying regulatory outcomes of Non-interventional Post-Authorisation Safety Studies (PASS) in the European repository of studies using publicly available informationFrontiers in Drug Safety and Regulation · 2025
20. What a SMART Pharmacist Can Discover in Only One Day: A Public Health Initiative Focused on Diabetes in North MacedoniaHealthcare · 2025